Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Valentis Posts Fallen Revenue, Widened Loss in Q3

NEW YORK, May 13 - Valentis on Friday reported that falling third-quarter revenue caused a widened net loss.


Total revenue for the period ended March 31 fell to $833,000 from $1 million in the year-ago quarter.


R&D followed suit, decreasing to $5.6 million in the third quarter 2002 from $6.9 million one year ago.


Net loss widened to $11 million, or $.30 per basic and diluted share compared with $10.2 million, or $.34 per basic and diluted share, year over year, the company reported


Valentis said it had roughly $25.2 million in cash, cash equivalents, and short-term investments as of March 31.


Click here for more information.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.